Could This Be the Turnaround That Aralez Pharma Is Looking For?
Aralez Pharmaceuticals saw its stock take a solid uptick early on Monday following a key approval in Canada.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 216
Performance Health Files for IPO
Performance Health Holdings has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Why Key Analyst Sees Huge Upside in Sarepta Therapeutics
Sarepta Therapeutics shares got crushed on Thursday and then exploded on Friday following the FDA view on its Duchenne muscular dystrophy treatment.
UnitedHealth Best Performing Dow Stock This Year
After a slow start to the year, the Dow Jones Industrial Average has perked up since March and now stands at just over 18,000, up 3.3% for the year to date. Of the Dow…
Parnell Pharma Soars on Business Update
Parnell Pharmaceuticals saw its shares take a sharp uptick into the weekend following the announcement of business results for the first quarter of 2016.
Why TransEnterix Shares Are in Free Fall
TransEnterix has announced that the FDA notified it that its SurgiBot System does not meet the criteria for substantial equivalence based on the data and information submitted.
American Renal Associates Prepares to Enter the Market With Updated IPO Filing
American Renal Associates expects to price more than 7 million shares in the range of $20 to $23 per share in an initial public offering valued up to more than $198 million.
Can BioMarin Make Treating Hemophilia More Affordable?
BioMarin Pharmaceutical is ready to break above the $1 billion revenue barrier in 2016, a feat that marks a major hurdle for many biotech and emerging pharmaceutical companies.
Spectrum Pharma Jumps on FDA Orphan Designation
Spectrum Pharmaceuticals announced that the FDA has granted seven years of Orphan Drug exclusivity for Evomela.
Cara Therapeutics Rises on FDA Judgment
Cara Therapeutics saw its shares jump early on Wednesday after it announced that it has received notice from the FDA that it has removed the clinical hold on its adaptive Phase 3 trial of…
Gemphire Therapeutics Gears Up for IPO
Gemphire Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Johnson & Johnson Raises Forecast on Weaker Dollar
Johnson & Johnson reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.
UnitedHealth Raises Outlook Following Strong Q1 Earnings
UnitedHealth Group reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.
Theranos Valuation May Drop to Zero
According to The Wall Street Journal, the reasons Theranos may lose all of its value have been bolstered by an SEC criminal investigation into whether management knowingly made false statements to investors.
Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys
New research from Jefferies highlights this week's top growth stock picks, and there is a clear bias for some top biotech and pharmaceutical stocks — and with good reason. They are cheap and have…